Last 47 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -12.25 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 2.64 | 2.39 | 1.79 | 2.07 | 2.16 | 3.13 | 3.17 | 4.98 | 2.73 | 3.07 | 3.03 | 2.98 | 3.39 | 8.75 | 13.00 | 15.00 | 15.21 | 12.91 | 15.69 | 14.64 | 22.55 |
| — | -23.4% | -43.6% | -58.5% | -20.7% | +1.9% | +4.7% | +66.9% | -19.5% | -64.9% | -76.7% | -80.1% | -77.7% | -32.2% | -17.1% | +2.4% | -32.6% | -70.0% | -37.7% | -56.0% | -1.1% | |
| P/B Ratio | 4.89 | 5.20 | 3.76 | 4.23 | 4.24 | 5.68 | 5.43 | 8.92 | 4.69 | 5.10 | 4.67 | 4.41 | 4.38 | 10.61 | 14.71 | 17.46 | 17.89 | 16.46 | 19.80 | 19.00 | 29.17 |
| — | -8.5% | -30.7% | -52.5% | -9.7% | +11.4% | +16.4% | +102.5% | +7.1% | -51.9% | -68.3% | -74.8% | -75.5% | -35.5% | -25.7% | -8.1% | -38.7% | -71.5% | -45.7% | -52.7% | -25.9% | |
| P/FCF | — | 79.53 | — | — | 24.23 | — | — | — | — | — | — | — | — | — | — | — | 119.18 | 156.30 | — | 14999.29 | 142.76 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -16.5% | -35.8% | — | +14859.9% | +33.1% | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1249.85 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -17.5% | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.5% | 77.6% | 77.6% | 75.8% | 73.2% | 73.9% | 75.1% | 79.2% | 77.2% | 77.0% | 75.7% | 75.7% | 74.8% | 73.0% | 75.8% | 77.5% | 77.3% | 79.8% | 79.8% | 77.7% | 77.4% |
| — | +5.0% | +3.3% | -4.3% | -5.1% | -4.0% | -0.7% | +4.7% | +3.2% | +5.4% | -0.1% | -2.4% | -3.2% | -8.5% | -5.1% | -0.3% | -0.1% | +1.5% | -0.7% | -3.4% | -1.5% | |
| Operating Margin | -23.5% | -5.8% | -38.7% | -23.2% | -21.5% | -24.9% | -24.4% | -39.3% | -20.7% | -22.4% | -30.0% | -38.7% | -45.7% | -49.7% | -49.3% | -33.5% | -18.8% | -15.0% | -0.6% | -17.6% | -6.4% |
| — | +76.9% | -58.6% | +41.0% | -4.1% | -11.3% | +18.5% | -1.5% | +54.8% | +55.0% | +39.2% | -15.5% | -143.5% | -231.4% | -8314.8% | -90.5% | -193.5% | -62.9% | -797.4% | -309.1% | -156.5% | |
| Net Margin | -20.8% | -8.5% | -40.9% | -14.1% | -22.3% | -25.3% | -22.1% | -40.9% | -19.7% | -22.2% | -28.0% | -35.2% | -38.9% | -45.6% | -43.4% | -29.0% | -20.3% | -17.0% | -3.4% | -19.9% | -9.8% |
| — | +66.3% | -84.6% | +65.6% | -13.1% | -13.9% | +20.9% | -16.2% | +49.3% | +51.3% | +35.6% | -21.2% | -91.6% | -167.3% | -1185.4% | -46.2% | -106.5% | -55.4% | -10.2% | -681.5% | -240.4% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -38.9% | -4.7% | -21.2% | -7.2% | -10.8% | -11.3% | -9.5% | -18.3% | -8.5% | -9.3% | -10.7% | -12.5% | -12.2% | -13.5% | -12.2% | -8.4% | -6.0% | -5.5% | -1.1% | -6.4% | -3.2% |
| — | +58.5% | -123.0% | +60.7% | -27.5% | -21.9% | +11.5% | -46.9% | +30.8% | +31.7% | +11.6% | -48.0% | -104.1% | -147.5% | -1006.6% | -31.0% | -85.0% | -43.8% | -12.9% | -611.9% | -200.3% | |
| ROA | -13.3% | -2.0% | -8.9% | -2.3% | -2.9% | -3.2% | -2.8% | -5.4% | -2.5% | -2.9% | -3.4% | -4.1% | -4.3% | -4.9% | -4.5% | -3.2% | -2.3% | -2.1% | -0.4% | -2.3% | -1.2% |
| — | +38.5% | -224.1% | +57.7% | -13.8% | -12.5% | +19.4% | -30.3% | +41.5% | +41.9% | +23.8% | -30.2% | -88.7% | -137.1% | -1005.0% | -34.7% | -92.2% | -53.5% | -4.2% | -453.1% | -161.2% | |
| ROIC | -16.4% | -1.7% | -10.2% | -4.6% | -3.2% | -3.2% | -3.1% | -5.5% | -2.8% | -3.7% | -5.1% | -5.0% | -5.2% | -5.6% | -5.2% | -3.8% | -2.6% | -2.1% | -0.1% | -3.3% | -1.4% |
| — | +48.3% | -224.0% | +16.4% | -13.9% | +12.1% | +38.6% | -9.4% | +46.3% | +34.3% | +1.5% | -31.6% | -102.5% | -160.6% | -6787.3% | -17.2% | -84.1% | -45.7% | -645.5% | -237.5% | -119.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.85 | 0.69 | 0.71 | 0.85 | 2.34 | 2.00 | 1.92 | 1.90 | 1.87 | 1.87 | 1.66 | 1.64 | 1.50 | 1.41 | 1.36 | 1.32 | 1.30 | 1.31 | 1.33 | 1.42 | 1.39 |
| — | -65.5% | -63.1% | -55.1% | +24.8% | +7.4% | +16.2% | +15.3% | +25.0% | +32.1% | +22.1% | +24.2% | +15.2% | +8.1% | +2.3% | -6.6% | -6.2% | -9.3% | -13.8% | +49.9% | +3154.7% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 320.31 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +27.7% | — | — | |
| Current Ratio | 2.90 | 2.89 | 2.90 | 2.90 | 1.55 | 1.45 | 1.47 | 1.46 | 1.49 | 6.46 | 6.26 | 5.78 | 6.67 | 7.10 | 7.32 | 7.00 | 7.81 | 8.08 | 8.46 | 7.53 | 8.58 |
| — | +100.2% | +98.1% | +98.0% | +3.8% | -77.6% | -76.6% | -74.7% | -77.7% | -9.0% | -14.5% | -17.5% | -14.7% | -12.2% | -13.4% | -7.0% | -9.0% | -10.2% | -8.0% | -14.4% | +113.4% | |
| Quick Ratio | 2.71 | 2.70 | 2.70 | 2.71 | 1.50 | 1.39 | 1.41 | 1.42 | 1.44 | 6.22 | 5.99 | 5.56 | 6.43 | 6.88 | 7.11 | 6.82 | 7.62 | 7.87 | 8.23 | 7.36 | 8.40 |
| — | +94.2% | +91.4% | +91.5% | +4.1% | -77.6% | -76.4% | -74.5% | -77.7% | -9.6% | -15.7% | -18.4% | -15.6% | -12.5% | -13.6% | -7.4% | -9.2% | -10.3% | -7.9% | -14.0% | +124.3% | |
| Interest Coverage | — | — | -36.68 | -73.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | -9.48 | -0.47 | — | -4.32 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NVCR stock.
Novocure Ltd's current P/E is -12.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Novocure Ltd's current operating margin is -23.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Novocure Ltd's business trajectory between earnings reports.